Results 121 to 130 of about 10,206 (212)

A principal component analysis-based endophenotype definition for change in lung function and inhaled corticosteroid treatment response in childhood asthma. [PDF]

Respir Res
Piparia S, Kho AT, Desai B, Wong R, Sharma R, Celedón JC, McGeachie MJ, Weiss ST, Tantisira KG.   +8 more
europepmc   +1 more source

Changes in lung function and health status in patients with COPD treated with tiotropium or salmeterol plus fluticasone [PDF]

, 2008
Kazuyoshi Kurashima, Kenichirou Hara, Kouichirou Yoneda, Tetsu Kanauchi, Naho Kagiyama, Daido Tokunaga, Noboru Takayanagi, Mikio Ubukata, Yutaka Sugita   +8 more
openalex   +1 more source

Implication of Central β₂ Adrenergic Receptor for the Development of Novel Drugs Against Alzheimer's Disease. [PDF]

Arch Pharm (Weinheim)
Wang A, Since M, Dallemagne P, Rochais C.   +3 more
europepmc   +1 more source

CHI PHÍ HIỆU QUẢ CỦA THUỐC KẾT HỢP SALMETEROL/FLUTICASONE PROPIONATE TRONG ĐIỀU TRỊ HEN PHẾ QUẢN KHÔNG KIỂM SOÁT TẠI VIỆT NAM

Lâm Tới Phùng, Thị Mai Phương Nguyễn, Quỳnh Trang Đỗ, Trà My Đỗ, Thế Duệ Ong, Thị Mai Hoa Nguyễn, Thị Thanh Vân Phan, Hoàn Lê Minh Nguyễn, Phansalkar Abhay, Hamouda Mohamed   +9 more
openalex   +2 more sources

Pharmacokinetic characteristics of fluticasone, salmeterol and tiotropium after concurrent inhalation [PDF]

, 2017
Jung Sunwoo, Su‐jin Rhee, SeungHwan Lee, Sang Won Lee, Jina Jung, Hankil Son, In‐Jin Jang   +6 more
openalex   +1 more source

Emulating randomized trials by observational database studies: the RCT-DUPLICATE initiative in COPD and asthma. [PDF]

Am J Epidemiol
Suissa S, Schneeweiss S, Feldman WB, Tesfaye H, Wang SV.   +4 more
europepmc   +1 more source

El tratamiento con indacaterol-glicopirronio fue más efectivo que salmeterol-fluticasona en la prevención de las exacerbaciones de la EPOC

, 2017
Horacio Matías Castro
openalex   +2 more sources

Budesonide-Formoterol Metered-Dose Inhaler vs Fluticasone-Salmeterol Dry-Powder Inhaler.

JAMA Intern Med
Rabin AS, Seelye SM, Weinstein JB, Hogan CK, Whittington TN, Cano J, Miller SA, Kelley C, Prescott HC.   +8 more
europepmc   +1 more source

Pharmacoeconomic evaluation of ICS-LABA therapy in pediatric asthma: a cost-effectiveness and cost-utility analysis. [PDF]

Front Pharmacol
Dai F, Xu J, Xu J, Li W.
europepmc   +1 more source

Structure and dynamics determine G protein coupling specificity at a class A GPCR. [PDF]

Sci Adv
Casiraghi M, Wang H, Brennan PC, Habrian C, Hübner H, Schmidt MF, Maul L, Pani B, Bahriz SMFM, Xu B, Staffen N, Assafa TE, Chen B, White E, Sunahara RK, Inoue A, Xiang YK, Lefkowitz RJ, Isacoff EY, Nucci N, Gmeiner P, Lerch MT, Kobilka BK.   +22 more
europepmc   +1 more source